Skip to content

Tenofovir Alafenamide

Tenofovir Alafenamide (Biktarvy) is an antiretroviral ingredient used in the treatment of HIV-1 infection. This is the only formulation of the ingredient listed in the MedicForce catalogue.

Biktarvy

Human Immunodeficiency Virus 1 (HIV-1) Infection

50mg + 200mg + 25mg

Bictegravir and emtricitabine tablets for HIV-1 infection. Two antiretrovirals work together to stop the virus from copying itself and spreading.

From$64.00/ tabletView

Key points

  • Tenofovir Alafenamide belongs to the antiretroviral class and is used in combination therapy for HIV-1 infection.
  • Biktarvy is the sole product in this catalogue; it is a tablet marketed by Gilead Sciences.
  • The tablet is taken by mouth; it is not a capsule, liquid or topical form.

What Tenofovir Alafenamide is used for

Tenofovir Alafenamide is listed for HIV-1 infection, a condition covered under the HIV Management category. Biktarvy contains three active ingredients, bictegravir, emtricitabine and tenofovir alafenamide, in a single tablet.

Further reading